{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:30:22Z","timestamp":1794029422147,"version":"4.8.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.mce.2017.06.013","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:17:31Z","timestamp":1497572251000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"special_numbering":"C","title":["Development of selective androgen receptor modulators (SARMs)"],"prefix":"10.1016","volume":"465","author":[{"given":"Ramesh","family":"Narayanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Coss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3915-7326","authenticated-orcid":false,"given":"James T.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2017.06.013_bib1","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/MCB.19.9.6085","article-title":"The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription","volume":"19","author":"Alen","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2017.06.013_bib2","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0510842103","article-title":"Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells","volume":"103","author":"Baek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2017.06.013_bib3","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1128\/MCB.19.12.8383","article-title":"The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1","volume":"19","author":"Bevan","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2017.06.013_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1677\/joe.1.06365","article-title":"Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men","volume":"191","author":"Blouin","year":"2006","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib5","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/jn\/133.7.2356","article-title":"The age-related decline in resting energy expenditure in humans is due to the loss of fat-free mass and to alterations in its metabolically active components","volume":"133","author":"Bosy-Westphal","year":"2003","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.mce.2017.06.013_bib6","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00204-012-0868-5","article-title":"Estrogen receptors and human disease: an update","volume":"86","author":"Burns","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.mce.2017.06.013_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0531-5565(01)00220-0","article-title":"The biochemistry of aging muscle","volume":"37","author":"Carmeli","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.mce.2017.06.013_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/mend.16.4.0818","article-title":"Evaluation of ligand-dependent changes in AR structure using peptide probes","volume":"16","author":"Chang","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tips.2005.03.002","article-title":"Androgen receptor-cofactor interactions as targets for new drug discovery","volume":"26","author":"Chang","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mce.2017.06.013_bib10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.3353726","article-title":"Molecular cloning of human and rat complementary DNA encoding androgen receptors","volume":"240","author":"Chang","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.mce.2017.06.013_bib11","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1128\/MCB.19.12.8226","article-title":"Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta","volume":"19","author":"Chang","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2017.06.013_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9378(16)35246-2","article-title":"Clomiphene in the treatment of oligomenorrhea and amenorrhea","volume":"86","author":"Charles","year":"1963","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2017.06.013_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jcsm.12161","article-title":"Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy","volume":"8","author":"Chu","year":"2016","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.mce.2017.06.013_bib14","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1210\/me.2013-1098","article-title":"Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element","volume":"27","author":"Clinckemalie","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.steroids.2014.06.010","article-title":"Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer","volume":"90","author":"Coss","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2017.06.013_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2013.03.003","article-title":"GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy","volume":"72","author":"Cozzoli","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mce.2017.06.013_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.mce.2017.06.013_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1998.8209","article-title":"Discovery of nonsteroidal androgens","volume":"244","author":"Dalton","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2017.06.013_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.mce.2017.06.013_bib20","doi-asserted-by":"crossref","first-page":"27882","DOI":"10.1074\/jbc.M605002200","article-title":"Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells","volume":"281","author":"Dehm","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/gyno.2000.5859","article-title":"Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer","volume":"78","author":"Deligdisch","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mce.2017.06.013_bib22","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1095\/biolreprod.102.003848","article-title":"Protective effects of estrogen and selective estrogen receptor modulators in the brain","volume":"67","author":"Dhandapani","year":"2002","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2017.06.013_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mce.2017.06.013_bib24","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/en.2015-1479","article-title":"Enobosarm (GTx-024) modulates adult skeletal muscle mass independently of the androgen receptor in the satellite cell lineage","volume":"156","author":"Dubois","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2017.06.013_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0960-894X(98)00107-3","article-title":"New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone","volume":"8","author":"Edwards","year":"1998","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.mce.2017.06.013_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2013a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.mce.2017.06.013_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.mce.2017.06.013_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2017.06.013_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcsm.12083","article-title":"Request for regulatory guidance for cancer cachexia intervention trials","volume":"6","author":"Fearon","year":"2015","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.mce.2017.06.013_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.steroids.2014.06.008","article-title":"Nuclear receptor modulation\u2013role of coregulators in selective estrogen receptor modulator (SERM) actions","volume":"90","author":"Feng","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2017.06.013_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0046-8177(76)80053-6","article-title":"The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis","volume":"7","author":"Frankel","year":"1976","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mce.2017.06.013_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0960-0760(94)90020-5","article-title":"The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects","volume":"50","author":"Fujimoto","year":"1994","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2017.06.013_bib33","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1074\/jbc.274.12.8316","article-title":"Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate","volume":"274","author":"Fujimoto","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib34","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1210\/en.2005-0572","article-title":"Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats","volume":"146","author":"Gao","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2017.06.013_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1124\/mi.7.1.3","article-title":"Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5{alpha}-reductase?","volume":"7","author":"Gao","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.mce.2017.06.013_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.etp.2004.07.002","article-title":"Testosterone influenced the expression of Notch1, Notch2 and Jagged1 induced by lipopolysaccharide in macrophages","volume":"56","author":"Guo","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.mce.2017.06.013_bib37","doi-asserted-by":"crossref","first-page":"36869","DOI":"10.1074\/jbc.R100029200","article-title":"The multifaceted mechanisms of estradiol and estrogen receptor signaling","volume":"276","author":"Hall","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib38","series-title":"Discovery and Preclinical Profile of a Highly Potent and Muscle Selective Androgen Receptor Modulator (SARM)","author":"Hamann","year":"2004"},{"key":"10.1016\/j.mce.2017.06.013_bib39","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1248\/bpb.26.1563","article-title":"Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis","volume":"26","author":"Hanada","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.mce.2017.06.013_bib40","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1074\/jbc.M111975200","article-title":"The FXXLF motif mediates androgen receptor-specific interactions with coregulators","volume":"277","author":"He","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/42750","article-title":"A\u00a0signature motif in transcriptional co-activators mediates binding to nuclear receptors","volume":"387","author":"Heery","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.mce.2017.06.013_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/edrv.23.2.0460","article-title":"Androgen receptor (AR) coregulators: an overview","volume":"23","author":"Heinlein","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2017.06.013_bib43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0960-894X(99)00186-9","article-title":"4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonists","volume":"9","author":"Higuchi","year":"1999","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.mce.2017.06.013_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0960-0760(02)00220-0","article-title":"Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs","volume":"82","author":"Holterhus","year":"2002","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2017.06.013_bib45","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1210\/endo.142.9.8402","article-title":"Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor","volume":"142","author":"Huber","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2017.06.013_bib46","first-page":"91","article-title":"Steroid 5alpha-reductase deficiency in man. An inherited form of male pseudohermaphroditism","volume":"11","author":"Imperato-McGinley","year":"1975","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.mce.2017.06.013_bib47","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1210\/mend-5-10-1396","article-title":"Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization","volume":"5","author":"Jenster","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib48","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1074\/jbc.270.13.7341","article-title":"Identification of two transcription activation units in the N-terminal domain of the human androgen receptor","volume":"270","author":"Jenster","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib49","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1210\/en.2010-0150","article-title":"Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy","volume":"151","author":"Jones","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2017.06.013_bib50","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1074\/jbc.274.13.8570","article-title":"Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor","volume":"274","author":"Kang","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib51","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1359\/JBMR.040306","article-title":"Nongenomic androgen activation of phosphatidylinositol 3-kinase\/Akt signaling pathway in MC3T3-E1 osteoblasts","volume":"19","author":"Kang","year":"2004","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.mce.2017.06.013_bib52","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","article-title":"Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase","volume":"270","author":"Kato","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.mce.2017.06.013_bib53","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1210\/me.2005-0309","article-title":"Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators","volume":"20","author":"Kazmin","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11095-006-9152-9","article-title":"Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats","volume":"24","author":"Kearbey","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mce.2017.06.013_bib55","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2017.06.013_bib56","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.mce.2017.06.013_bib57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0039-128X(96)00174-2","article-title":"The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology","volume":"62","author":"Labrie","year":"1997","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2017.06.013_bib58","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen","volume":"81","author":"Lahti","year":"1993","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mce.2017.06.013_bib59","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1021\/bi702220p","article-title":"Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a","volume":"47","author":"Lavery","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2017.06.013_bib60","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2017.06.013_bib61","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1074\/jbc.M206374200","article-title":"Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT","volume":"278","author":"Liao","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.mce.2017.06.013_bib63","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1021\/jm050205o","article-title":"Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators","volume":"48","author":"Link","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib64","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1073\/pnas.122225699","article-title":"Coactivator\/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486","volume":"99","author":"Liu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2017.06.013_bib65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00436-006-0168-1","article-title":"Testosterone attenuates p38 MAPK pathway during Leishmania donovani infection of macrophages","volume":"99","author":"Liu","year":"2006","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.mce.2017.06.013_bib66","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.21873\/anticanres.11278","article-title":"Decreased skeletal muscle mass after neoadjuvant therapy correlates with poor prognosis in patients with esophageal cancer","volume":"36","author":"Liu","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mce.2017.06.013_bib67","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/mend-2-12-1265","article-title":"The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate","volume":"2","author":"Lubahn","year":"1988","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib68","doi-asserted-by":"crossref","first-page":"41512","DOI":"10.1074\/jbc.M006757200","article-title":"G\u00a0protein beta gamma subunits inhibit nongenomic progesterone-induced signaling and maturation in Xenopus laevis oocytes. Evidence for a release of inhibition mechanism for cell cycle progression","volume":"275","author":"Lutz","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib69","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.241471598","article-title":"Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation","volume":"98","author":"Lutz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2017.06.013_bib70","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1210\/me.2003-0032","article-title":"Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands","volume":"17","author":"Lutz","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib71","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1471-2407-13-425","article-title":"Estrogen receptor alpha\/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer","volume":"13","author":"Madeira","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mce.2017.06.013_bib72","first-page":"1728","article-title":"Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice","volume":"10","author":"Mani","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib73","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1997.12.9.1431","article-title":"Effects of dihydrotestosterone on bone biochemical markers in sham and oophorectomized rats","volume":"12","author":"Mason","year":"1997","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.mce.2017.06.013_bib74","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cas.12121","article-title":"Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation","volume":"104","author":"McNamara","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mce.2017.06.013_bib75","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4065\/75.8.821","article-title":"Prevention and treatment of osteoporosis in women with breast cancer","volume":"75","author":"Mincey","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.mce.2017.06.013_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/en.2006-0793","article-title":"An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate","volume":"148","author":"Miner","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2017.06.013_bib77","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/BJ20071352","article-title":"Identification of androgen-selective androgen-response elements in the human aquaporin-5 and Rad9 genes","volume":"411","author":"Moehren","year":"2008","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.mce.2017.06.013_bib78","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1517\/13543776.15.11.1565","article-title":"Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidates","volume":"15","author":"Mohler","year":"2005","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.mce.2017.06.013_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/edrv-8-1-1","article-title":"Biological actions of androgens","volume":"8","author":"Mooradian","year":"1987","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2017.06.013_bib80","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00391-004-0203-8","article-title":"Sarcopenia and frailty in geriatric patients: implications for training and prevention","volume":"37","author":"Muhlberg","year":"2004","journal-title":"Z\u00a0Gerontol. Geriatr."},{"key":"10.1016\/j.mce.2017.06.013_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8120108","article-title":"Androgen receptor: a complex therapeutic target for breast cancer","volume":"8","author":"Narayanan","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mce.2017.06.013_bib82","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1210\/me.2008-0160","article-title":"Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways","volume":"22","author":"Narayanan","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib83","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/0008-5472.CAN-09-3206","article-title":"Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer","volume":"70","author":"Narayanan","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2017.06.013_bib84","doi-asserted-by":"crossref","first-page":"19900","DOI":"10.1074\/jbc.271.33.19900","article-title":"Activation of the human androgen receptor through a protein kinase A signaling pathway","volume":"271","author":"Nazareth","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2009.03700.x","article-title":"Steroid hormone transforming aldo-keto reductases and cancer","volume":"1155","author":"Penning","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mce.2017.06.013_bib86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3510067","article-title":"Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones","volume":"351","author":"Penning","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2017.06.013_bib87","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jsxm.2016.06.003","article-title":"Effects of 8-year treatment of long-acting testosterone undecanoate on metabolic parameters, urinary symptoms, bone mineral density, and sexual function in men with late-onset hypogonadism","volume":"13","author":"Permpongkosol","year":"2016","journal-title":"J.\u00a0Sex. Med."},{"key":"10.1016\/j.mce.2017.06.013_bib88","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1158\/0008-5472.CAN-09-0452","article-title":"Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer","volume":"69","author":"Peters","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2017.06.013_bib89","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","article-title":"Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies","volume":"275","author":"Politano","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.mce.2017.06.013_bib90","article-title":"Tissue selective androgen receptor modulators (SARMs) increase pelvic floor muscle mass in ovariectomized mice","author":"Ponnusamy","year":"2016","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.mce.2017.06.013_bib91","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jcb.25751","article-title":"Tissue selective androgen receptor modulators (SARMs) increase pelvic floor muscle mass in ovariectomized mice","volume":"118","author":"Ponnusamy","year":"2017","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.mce.2017.06.013_bib92","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0165-6147(92)90099-R","article-title":"New insights into activation of the steroid hormone receptor superfamily","volume":"13","author":"Power","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mce.2017.06.013_bib93","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1083\/jcb.201212142","article-title":"The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy","volume":"201","author":"Rahimov","year":"2013","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.mce.2017.06.013_bib94","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mce.2017.06.013_bib95","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/39.7.1865110","article-title":"Androgen receptor expression in human tissues: an immunohistochemical study","volume":"39","author":"Ruizeveld de Winter","year":"1991","journal-title":"J.\u00a0Histochem Cytochem"},{"key":"10.1016\/j.mce.2017.06.013_bib96","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0079-6123(08)63689-4","article-title":"Metabolism of androstenedione and testosterone in human fetal brain","volume":"42","author":"Schindler","year":"1975","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.mce.2017.06.013_bib97","doi-asserted-by":"crossref","first-page":"17054","DOI":"10.1074\/jbc.M109.099002","article-title":"Discovery of the selective androgen receptor modulator MK-0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiology","volume":"285","author":"Schmidt","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib98","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-16-2339","article-title":"A\u00a0phase I\/Ib study of enzalutamide alone and in combination with endocrine therapies in women with advanced breast cancer","author":"Schwartzberg","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2017.06.013_bib99","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1097-2765(02)00471-9","article-title":"Formation of the androgen receptor transcription complex","volume":"9","author":"Shang","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mce.2017.06.013_bib100","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.mce.2017.06.013_bib101","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0021-9258(18)52466-2","article-title":"Transcriptional activation and nuclear targeting signals of the human androgen receptor","volume":"266","author":"Simental","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.06.013_bib102","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1210\/jc.2004-0084","article-title":"Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment","volume":"89","author":"Sinha-Hikim","year":"2004","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.06.013_bib103","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","article-title":"Coregulator function: a key to understanding tissue specificity of selective receptor modulators","volume":"25","author":"Smith","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2017.06.013_bib104","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/mend.11.6.0009","article-title":"Coactivator and corepressor regulation of the agonist\/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen","volume":"11","author":"Smith","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.06.013_bib105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/fon.13.273","article-title":"Enobosarm (GTx-024, S-22): a potential treatment for cachexia","volume":"10","author":"Srinath","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.mce.2017.06.013_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2014.04.004","article-title":"Expression of the androgen receptor, pAkt, and pPTEN in breast cancer and their potential in prognostication","author":"Sultana","year":"2014","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.mce.2017.06.013_bib107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(02)02958-8","article-title":"CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton","volume":"461","author":"Tabata","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mce.2017.06.013_bib108","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mce.2017.06.013_bib109","doi-asserted-by":"crossref","first-page":"R566","DOI":"10.1152\/ajpregu.00174.2016","article-title":"Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined?","volume":"311","author":"Traish","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2017.06.013_bib110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.bi.63.070194.002315","article-title":"Molecular mechanisms of action of steroid\/thyroid receptor superfamily members","volume":"63","author":"Tsai","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.mce.2017.06.013_bib111","doi-asserted-by":"crossref","first-page":"e48385","DOI":"10.1371\/journal.pone.0048385","article-title":"Org 214007\u20130: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index","volume":"7","author":"van Lierop","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2017.06.013_bib112","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1042\/BST0341089","article-title":"The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response","volume":"34","author":"Verrijdt","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.mce.2017.06.013_bib113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00520-014-2332-y","article-title":"Loss of muscle mass in the end of life in patients with advanced cancer","volume":"23","author":"Wallengren","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.mce.2017.06.013_bib114","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/biof.66","article-title":"Steroid receptor phosphorylation: assigning function to site-specific phosphorylation","volume":"35","author":"Ward","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.mce.2017.06.013_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-60327-575-0_12","article-title":"Using intrinsic fluorescence emission spectroscopy to study steroid receptor and coactivator protein conformation dynamics","volume":"505","author":"Watt","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mce.2017.06.013_bib116","unstructured":"GTx Reports Results from Ongoing Enobosarm Phase 2 Clinical Trial in ER+\/AR+ Breast Cancer. 2016."},{"key":"10.1016\/j.mce.2017.06.013_bib117","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1124\/mol.63.1.211","article-title":"Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor","volume":"63","author":"Yin","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2017.06.013_bib118","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1002\/j.1460-2075.1992.tb05453.x","article-title":"Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors","volume":"11","author":"Ylikomi","year":"1992","journal-title":"Embo J."},{"key":"10.1016\/j.mce.2017.06.013_bib119","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1016\/S0021-9258(17)36806-0","article-title":"A\u00a0ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences","volume":"269","author":"Zhou","year":"1994","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720717303404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720717303404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T19:12:09Z","timestamp":1659121929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720717303404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":119,"alternative-id":["S0303720717303404"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2017.06.013","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of selective androgen receptor modulators (SARMs)","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2017.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}